DE69829637D1 - Vorrichtung zur intraokularen Übertragung von aktiven Wirkstoffen durch Iontophorese - Google Patents

Vorrichtung zur intraokularen Übertragung von aktiven Wirkstoffen durch Iontophorese

Info

Publication number
DE69829637D1
DE69829637D1 DE69829637T DE69829637T DE69829637D1 DE 69829637 D1 DE69829637 D1 DE 69829637D1 DE 69829637 T DE69829637 T DE 69829637T DE 69829637 T DE69829637 T DE 69829637T DE 69829637 D1 DE69829637 D1 DE 69829637D1
Authority
DE
Germany
Prior art keywords
iontophoresis
reservoir
intraocular
transmission
active agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829637T
Other languages
English (en)
Other versions
DE69829637T2 (de
Inventor
Jean-Marie Parel
Francine Behar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EyeGate Pharma SAS
Original Assignee
Optis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optis SA filed Critical Optis SA
Application granted granted Critical
Publication of DE69829637D1 publication Critical patent/DE69829637D1/de
Publication of DE69829637T2 publication Critical patent/DE69829637T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
DE69829637T 1998-01-05 1998-12-17 Vorrichtung zur intraokularen Übertragung von aktiven Wirkstoffen durch Iontophorese Expired - Lifetime DE69829637T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800009A FR2773320B1 (fr) 1998-01-05 1998-01-05 Dispositif pour le transfert intraoculaire de produits actifs par iontophorese
FR9800009 1998-01-05

Publications (2)

Publication Number Publication Date
DE69829637D1 true DE69829637D1 (de) 2005-05-12
DE69829637T2 DE69829637T2 (de) 2006-03-09

Family

ID=9521510

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69841028T Expired - Lifetime DE69841028D1 (de) 1998-01-05 1998-12-17 Vorrichtung zur okularen Iontophorese zur Verabreichung mehrerer Wirkstoffe
DE69829637T Expired - Lifetime DE69829637T2 (de) 1998-01-05 1998-12-17 Vorrichtung zur intraokularen Übertragung von aktiven Wirkstoffen durch Iontophorese

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69841028T Expired - Lifetime DE69841028D1 (de) 1998-01-05 1998-12-17 Vorrichtung zur okularen Iontophorese zur Verabreichung mehrerer Wirkstoffe

Country Status (13)

Country Link
US (1) US6154671A (de)
EP (2) EP0927560B1 (de)
JP (1) JP4308353B2 (de)
KR (1) KR100551706B1 (de)
AT (2) ATE437672T1 (de)
BR (1) BR9900009A (de)
CA (1) CA2257749C (de)
DE (2) DE69841028D1 (de)
DK (1) DK0927560T3 (de)
ES (2) ES2327636T3 (de)
FR (1) FR2773320B1 (de)
IL (1) IL127711A (de)
PT (1) PT927560E (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6101411A (en) * 1998-09-24 2000-08-08 Newsome; David A. Dilation enhancer
US7346389B1 (en) * 1998-09-24 2008-03-18 Newsome David A Dilation enhancer with pre-medicated contact lenses
US7252655B2 (en) 1999-05-25 2007-08-07 Iomed, Inc. Ocular iontophoretic apparatus handle
US6728573B1 (en) 2000-02-23 2004-04-27 Iomed, Inc. Ocular iontophoretic apparatus handle
US6319240B1 (en) * 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
US6539251B2 (en) 1999-05-25 2003-03-25 Iomed, Inc. Ocular iontophoretic apparatus
US6546283B1 (en) 2000-10-18 2003-04-08 Iomed, Inc. High current density iontophoretic device and method of use thereof
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
US7031776B2 (en) * 2001-06-29 2006-04-18 Optobionics Methods for improving damaged retinal cell function
US20050004625A1 (en) * 2001-06-29 2005-01-06 Chow Alan Y. Treatment of degenerative retinal disease via electrical stimulation of surface structures
US20040106965A1 (en) * 2001-06-29 2004-06-03 Chow Alan Y. Methods and apparatus for treatment of degenerative retinal disease via indirect electrical stimulation
US20050033202A1 (en) * 2001-06-29 2005-02-10 Chow Alan Y. Mechanically activated objects for treatment of degenerative retinal disease
DE60219189T2 (de) * 2001-07-20 2008-01-03 Iomed, Inc., Salt Lake City Iontophoretische okularvorrichtung zur abgabe von medikamenten auf methotrexat-basis und deren verwendung zur behandlung von neoplastischen, angiogenen, fibroplastischen und/oder immunsuppressiven augenunregelmässigkeiten
AU2002316724A1 (en) * 2001-07-20 2003-03-03 Iomed, Inc. Ophthalmic use of 5 fluorourcil
FR2830766B1 (fr) 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese transpalpebrale
FR2830767B1 (fr) * 2001-10-12 2004-03-12 Optis France Sa Dispositif de delivrance de medicaments par iontophorese ou electroporation introculaire
FR2836832B1 (fr) 2002-03-08 2005-02-04 Optis France Sa Ensemble de connexion a usage medical pour le transfert de fluides
WO2003096991A2 (en) 2002-05-17 2003-11-27 Othera Pharmaceuticals, Inc. Amelioration of the development of cataracts and other opthalmic diseases
FR2851912B1 (fr) 2003-03-03 2005-05-13 Optis France Sa Connecteur d'alimentation uniforme pour des dispositifs de delivrance de principes actifs
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
US7589107B2 (en) 2003-05-19 2009-09-15 Othera Holding, Inc. Amelioration of vitrectomy-induced cataracts
FR2855761B1 (fr) * 2003-06-03 2006-02-24 Optis France Sa Dispositif oculaire de delivrance variable de principes actifs par iontophorese
EP2052720A3 (de) 2003-11-20 2009-05-06 Othera Holding, Inc. Verwendung von mindestens einer Hydroxylamin-Verbindung zur Behandlung einer Augenkrankheit
JP2007521124A (ja) * 2004-02-06 2007-08-02 シフィックス リミテッド ライアビリティ カンパニー 電気エネルギー、光エネルギー、および音響エネルギーのうち少なくともいずれか１つを用いる視覚障害の治療
BRPI0509334A (pt) 2004-04-30 2007-10-16 Eyegate Pharma S A dispositivo de iontoforese ocular, que diminui as irritações
FR2869531B1 (fr) * 2004-04-30 2006-07-14 Optis France Sa Sa Dispositif de iontophorese oculaire diminuant les irritations
CN1964711A (zh) * 2004-05-25 2007-05-16 奥特拉药物公司 眼睛选择性药物及前体药物
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
WO2006058189A2 (en) * 2004-11-23 2006-06-01 Wong Jr Edward K Medical device for temperature control and treatment of the eye and surrounding tissues
US8262715B2 (en) * 2004-11-23 2012-09-11 Eye Delivery System, Llc Medical device and method for temperature control and treatment of the eye and surrounding tissues via magnetic drug therapy
US20070282282A1 (en) * 2004-11-23 2007-12-06 Wong Edward K Jr Medical device and method for temperature control and treatment of the eye and surrounding tissues
WO2006072887A1 (en) * 2005-01-05 2006-07-13 Eyegate Pharma Sa Ocular iontophoresis device for delivering sirna and aptamers
JP5000638B2 (ja) * 2005-04-18 2012-08-15 アンスティテュー・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル・（イ・エヌ・エス・ウ・エール・エム） 対象の眼球に対して治療用生成物を送達するための改良型方法及び装置
WO2006127592A2 (en) * 2005-05-26 2006-11-30 Othera Pharmaceuticals, Inc. Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
US20070260171A1 (en) * 2005-09-27 2007-11-08 Higuchi John W Intraocular iontophoretic device and associated methods
US8755880B2 (en) * 2005-10-24 2014-06-17 Aciont, Inc. Intraocular iontophoretic device and associated methods
US8634907B2 (en) 2005-10-24 2014-01-21 Aciont, Inc. Intraocular iontophoretic device and associated methods
EP1940507A4 (de) * 2005-10-24 2011-04-20 Aciont Inc Intraokulare iontophoretische vorrichtung und relevante verfahren
FR2893852B1 (fr) * 2005-11-29 2010-09-03 Eyegate Pharma Sa Dispositif d'iontophorese oculaire
US8099162B2 (en) 2005-11-29 2012-01-17 Eyegate Pharma, S.A.S. Ocular iontophoresis device
US20070203190A1 (en) * 2006-02-22 2007-08-30 Ghanshyam Patil Hydroxylamines and derivatives for the inhibition of complement activation
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JPWO2007123142A1 (ja) * 2006-04-20 2009-09-03 Ｔｔｉ・エルビュー株式会社 イオントフォレーシス装置
US20070299386A1 (en) * 2006-06-23 2007-12-27 Minu, L.L.C. Delivery of an ocular agent using iontophoresis
WO2008013913A2 (en) * 2006-07-26 2008-01-31 Aciont, Inc. Method and device for minimally invasive site specific ocular drug delivery
US8923961B2 (en) 2006-10-18 2014-12-30 The Cleveland Clinic Foundation Electrode assembly for delivering a therapeutic agent into ocular tissue
CA2679066A1 (en) 2007-02-22 2008-08-28 Othera Holding, Inc. Hydroxylamine compounds and methods of their use
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US8480638B2 (en) * 2007-10-04 2013-07-09 Aciont, Inc. Intraocular iontophoretic device and associated methods
WO2009076220A1 (en) * 2007-12-05 2009-06-18 Eyegate Pharma S.A.S. Methods for delivering sirna via iontophoresis
WO2009108626A2 (en) * 2008-02-25 2009-09-03 Eyegate Pharma S.A.S. Enhanced delivery of a therapeutic to ocular tissues through iontophoresis
FR2928536B1 (fr) 2008-03-14 2012-04-27 Inst Nat Sante Rech Med Dispositif d'injection dans l'oeil
MX2011006925A (es) * 2008-12-31 2011-07-28 Eyegate Pharma S A S Sistema y metodo de iontoforesis ocular con amortiguacion.
JP5890182B2 (ja) 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
US10413506B2 (en) 2010-04-03 2019-09-17 Praful Doshi Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
CA2794956C (en) 2010-04-03 2017-05-02 Praful Doshi Medical devices including medicaments and methods of making and using same
CA2803923A1 (en) 2010-06-25 2011-12-29 Ignacio R. Rodriguez Methods of treatment using sterculic acid
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
EP2648663B1 (de) 2011-01-12 2015-03-25 Sooft Italia Spa Vorrichtung für die abgabe von riboflavin mittels iontophorese zur behandlung von keratokonus
WO2012162459A1 (en) * 2011-05-26 2012-11-29 Pepose Jay Device and method for administering eye medications
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
KR20190090048A (ko) 2011-12-05 2019-07-31 인셉트, 엘엘씨 의료용 유기젤 방법 및 조성물
CA2940513C (en) 2013-03-11 2023-08-15 University Of Florida Research Foundation, Inc. Delivery of card protein as therapy for ocular inflammation
BR112015027762A2 (pt) 2013-05-03 2017-08-29 Clearside Biomedical Inc Aparelho e métodos para injeção ocular
ITVE20130043A1 (it) * 2013-07-31 2015-02-01 I A C E R S R L Dispositivo perfezionato oftalmologico per il trattamento di malattie corneali quali il cheratocono.
ES2672327T3 (es) * 2014-01-27 2018-06-13 Opia Technologies Dispositivo de iontoforesis ocular
JP5828535B1 (ja) * 2014-10-10 2015-12-09 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ
CN104353183B (zh) * 2014-10-31 2016-12-07 厦门微科格瑞生物科技有限公司 电解液位置固定的可佩戴智能药物导入结构
CA2973595A1 (en) * 2015-01-22 2016-07-28 Eyegate Pharmaceuticals, Inc. Iontophoretic contact lens
US10206814B2 (en) * 2016-01-06 2019-02-19 David R. Hardten System and method for the delivery of medications or fluids to the eye
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
WO2018175654A1 (en) 2017-03-23 2018-09-27 Doheny Eye Institute Systems, methods, and devices for optical coherence tomgraphy multiple enface angiography averaging
EP3860703A1 (de) 2018-10-01 2021-08-11 Biovisics Medical, Inc. System und verfahren zur gesteuerten elektrischen modulation für sehtherapie
US11305118B2 (en) 2018-11-30 2022-04-19 Biovisics Medical, Inc. Head worn apparatuses for vision therapy
WO2020146358A1 (en) 2019-01-09 2020-07-16 Verily Life Sciences Llc Programmable therapeutic agent delivery from eye mounted device
US11399976B2 (en) 2019-01-09 2022-08-02 Twenty Twenty Therapeutics Llc Eye mounted device for therapeutic agent release
WO2020210471A1 (en) 2019-04-10 2020-10-15 Biovisics Medical, Inc. Systems and interfaces for ocular therapy
US11511112B2 (en) 2019-06-14 2022-11-29 Biovisics Medical, Inc. Wearable medical device
CN110547907A (zh) * 2019-08-15 2019-12-10 中南大学湘雅二医院 一种用于眼内手术的双环虹膜扩张器
WO2024009535A1 (ja) * 2022-07-08 2024-01-11 テルモ株式会社 眼内薬物投与装置、薬剤リザーバ及び眼内薬物投与装置の動作方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US551880A (en) * 1895-12-24 Theodore b
US2525381A (en) * 1947-09-25 1950-10-10 Tower Paul Contact-type electrode holder
US3122137A (en) * 1961-10-30 1964-02-25 Erlanger Gustav Device for facilitating iontophoresis treatment of eyes
SU995783T (en) 1980-07-21 1983-02-15 Omskij G Med I A device for drug electrophoresis in ocular tissue
US4678466A (en) * 1981-06-25 1987-07-07 Rosenwald Peter L Internal medication delivery method and vehicle
US4564016A (en) 1982-05-24 1986-01-14 The Board Of Trustees Of The Leland Stanford Junior University Apparatus for introducing ionized drugs into the posterior segment of the eye and method
US5053000A (en) * 1985-11-13 1991-10-01 Imperial Chemical Industries Plc Ocular treatment
IL86076A (en) * 1988-04-14 1992-12-01 Inventor S Funding Corp Ltd Transdermal drug delivery device
US4955378A (en) * 1988-05-02 1990-09-11 University Of South Florida Apparatus and methods for performing electrofusion at specific anatomical sites
EP0464138A1 (de) * 1989-03-17 1992-01-08 Candela Laser Corporation Lasertherapiestrahlgerät für glaukombehandlung
US5174304A (en) * 1990-02-16 1992-12-29 Latina Mark A Electrocycloablation apparatus and method
US5472436A (en) * 1994-07-26 1995-12-05 Fremstad; Daria A. Ocular appliance for delivering medication
US5522864A (en) * 1994-10-25 1996-06-04 Wallace; Larry B. Apparatus and method for ocular treatment
AUPM982694A0 (en) * 1994-12-02 1995-01-05 University Of Queensland, The Iontophoresis method and apparatus
US5676648A (en) * 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use

Also Published As

Publication number Publication date
DK0927560T3 (da) 2005-08-15
JPH11244323A (ja) 1999-09-14
IL127711A0 (en) 1999-10-28
ATE437672T1 (de) 2009-08-15
IL127711A (en) 2004-06-20
DE69841028D1 (de) 2009-09-10
ES2327636T3 (es) 2009-11-02
US6154671A (en) 2000-11-28
EP0927560A1 (de) 1999-07-07
KR100551706B1 (ko) 2006-07-06
PT927560E (pt) 2005-07-29
CA2257749A1 (en) 1999-07-05
ATE292493T1 (de) 2005-04-15
DE69829637T2 (de) 2006-03-09
KR19990066875A (ko) 1999-08-16
BR9900009A (pt) 2001-03-20
EP1452203B1 (de) 2009-07-29
EP1452203A2 (de) 2004-09-01
FR2773320B1 (fr) 2000-03-03
EP1452203A3 (de) 2004-09-08
FR2773320A1 (fr) 1999-07-09
JP4308353B2 (ja) 2009-08-05
EP0927560B1 (de) 2005-04-06
ES2236880T3 (es) 2005-07-16
CA2257749C (en) 2009-03-24

Similar Documents

Publication Publication Date Title
DE69829637D1 (de) Vorrichtung zur intraokularen Übertragung von aktiven Wirkstoffen durch Iontophorese
Szeto et al. Sensory feedback using electrical stimulation of the tactile sense
Kane et al. A history of local electrical analgesia
US6101411A (en) Dilation enhancer
US3991755A (en) Iontophoresis apparatus for applying local anesthetics
US6083250A (en) Apparatus and method for inhibiting lesion formation by selectively treating the prodromal stage of the lesion with a pulsatile electrical stimulation
ATE303757T1 (de) Behandlung von augenerkrankungen
EP2158937A3 (de) Künstliche Netzhautvorrichtung
EP0027363A1 (de) Verband zur Schmerzblockierung
ATE137658T1 (de) Vorrichtung zur behandlung von augen
WO2003039622A3 (en) Novel iontophoretic drug delivery systems
CN108744272A (zh) 鼻刺激装置和方法
ATE268624T1 (de) Vorrichtung zur abgabe von elektrischen stimuli an gewebe
ATE179339T1 (de) Elektrische stimulierung zur behandlung von inkontinenz und anderen neuromuskularerkrankungen
EP1754453A3 (de) Skleraprothese zur Behandlung der Weitsichtigkeit und anderer Augenkrankheiten
White Pain after amputation and its treatment
DE69724168D1 (de) Vorrichtung zur Behandlung des menschlichen Körpers durch endermatische Elektrotherapie
Dillman et al. Levator myectomy in synkinetic ptosis
AU2017204782B2 (en) Nasal stimulation devices and methods
Landau A physiological-anatomical analysis of nerve function: the peripheral pathway for pain
Sukhomlinova et al. Normal Physiology. Module 1
KR20030061993A (ko) 미소전류를 이용한 상처 치료기
Rosenburgh Pain—theories and treatment by cutaneous afferent stimulation
Jackson Vision with Closed Lids
RU98119433A (ru) Способ лечения заболеваний роговицы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EYEGATE PHARMA SAS, PARIS, FR